{"id":2141,"date":"2022-12-07T10:58:56","date_gmt":"2022-12-07T10:58:56","guid":{"rendered":"https:\/\/ad-es.org\/?p=2141"},"modified":"2025-05-28T08:49:09","modified_gmt":"2025-05-28T08:49:09","slug":"bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas","status":"publish","type":"post","link":"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/","title":{"rendered":"Increasingly resistant bacteria with no innovative drugs for six decades"},"content":{"rendered":"\n<p><em>La resistencia antimicrobiana es uno de los grandes problemas de la salud p\u00fablica mundial. Casi todos los antibi\u00f3ticos introducidos en el mercado son versiones mejoradas de los productos de amplio espectro aprobados antes de 1962. La OMS advierte de que la investigaci\u00f3n en este campo est\u00e1 &#8220;estancada&#8221;.<\/em><\/p>\n\n\n\n<p><em>Gargallo-Viola, CEO y CSO de ABAC Therapeutics, que participa en este articulo, es presidente de la Asociaci\u00f3n para el Descubrimiento de Nuevos Antibi\u00f3ticos en Espa\u00f1a (AD-ES) y portavoz en nuestro pa\u00eds de la Alianza europea <\/em><em>BEAM (Biotechs from Europe innovating in Anti-Microbial<\/em><em> resistance), creada en 2015 para fomentar la l+D de nuevos antibi\u00f3ticos y desarrollar nuevas estrategias para combatir la resistencia bacteriana.<\/em><\/p>\n\n\n\n<p><em>La Alianza europea BEAM, de la cual Domingo es el representante espa\u00f1ol, est\u00e1 compuesta por 68 miembros repartidos por 16 pa\u00edses de Europa. \u201cEstas compa\u00f1\u00edas<\/em><\/p>\n\n\n\n<p><em>est\u00e1n gestionando del orden de 130 proyectos en fase de descubrimiento y desarrollo de nuevos antibi\u00f3ticos\u201d, detalla. \u201cEn este momento concentran el 80% de la cartera de productos activos frente a bacterias multirresistentes. A nivel global, el 79% de los proyectos precl\u00ednicos (171 de 217) est\u00e1n bajo el paraguas de las Pymes y, a nivel cl\u00ednico, 59 de 80 proyectos\u201d.<\/em><\/p>\n\n\n\n<p><em>Los clientes de estas pymes y de las start-ups son las grandes farmac\u00e9uticas, encargadas del desarrollo y posterior comercializaci\u00f3n de los medicamentos, \u201cpero muchas de ellasno est\u00e1n interesadas en -antibioticos , con lo cual la cadena de valor en el \u00e1rea de las enfermedades infecciosas est\u00e1 rota\u201d.<\/em><\/p>\n\n\n\n<p><em>Como incentivos necesarios para acabar con el circulo establecido, Gargallo-Viola sugiere que deben orientarse a impulsar la actividad de investigaci\u00f3n y desarrollo de nuevas clases de agentes antimicrobianos, pero tambi\u00e9n otros destinados a apoyar la comercializaci\u00f3n de nuevas mol\u00e9culas de manera que garanticen a las empresas el retorno de la inversi\u00f3n que supone desarrollar y posicionar un antibiotico en el mercado\u201d. S\u00f3lo as\u00ed podr\u00eda ponerse fin a esta pandemia silenciosa.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La resistencia antimicrobiana es uno de los grandes problemas de la salud p\u00fablica mundial. Casi todos los antibi\u00f3ticos introducidos en el mercado son versiones mejoradas de los productos de amplio espectro aprobados antes de 1962. La OMS advierte de que la investigaci\u00f3n en este campo est\u00e1 &#8220;estancada&#8221;. Gargallo-Viola, CEO y CSO de ABAC Therapeutics, que [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"editor_notices":[],"footnotes":""},"categories":[11],"tags":[],"class_list":["post-2141","post","type-post","status-publish","format-standard","hentry","category-noticias-de-interes-para-ad-es"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Increasingly resistant bacteria with no innovative drugs for six decades - AD-ES<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Increasingly resistant bacteria with no innovative drugs for six decades - AD-ES\" \/>\n<meta property=\"og:description\" content=\"La resistencia antimicrobiana es uno de los grandes problemas de la salud p\u00fablica mundial. Casi todos los antibi\u00f3ticos introducidos en el mercado son versiones mejoradas de los productos de amplio espectro aprobados antes de 1962. La OMS advierte de que la investigaci\u00f3n en este campo est\u00e1 &#8220;estancada&#8221;. Gargallo-Viola, CEO y CSO de ABAC Therapeutics, que [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/\" \/>\n<meta property=\"og:site_name\" content=\"AD-ES\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-07T10:58:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-28T08:49:09+00:00\" \/>\n<meta name=\"author\" content=\"G3m4-tio-AD-ES\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"G3m4-tio-AD-ES\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/\"},\"author\":{\"name\":\"G3m4-tio-AD-ES\",\"@id\":\"https:\/\/ad-es.es\/en\/#\/schema\/person\/02319ca6a45506b4328ab7ef566c3a8c\"},\"headline\":\"Increasingly resistant bacteria with no innovative drugs for six decades\",\"datePublished\":\"2022-12-07T10:58:56+00:00\",\"dateModified\":\"2025-05-28T08:49:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/\"},\"wordCount\":336,\"publisher\":{\"@id\":\"https:\/\/ad-es.es\/en\/#organization\"},\"articleSection\":[\"News of interest to AD-ES\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/\",\"url\":\"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/\",\"name\":\"Increasingly resistant bacteria with no innovative drugs for six decades - AD-ES\",\"isPartOf\":{\"@id\":\"https:\/\/ad-es.es\/en\/#website\"},\"datePublished\":\"2022-12-07T10:58:56+00:00\",\"dateModified\":\"2025-05-28T08:49:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/ad-es.es\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Increasingly resistant bacteria with no innovative drugs for six decades\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ad-es.es\/en\/#website\",\"url\":\"https:\/\/ad-es.es\/en\/\",\"name\":\"AD-ES\",\"description\":\"Asociaci\u00f3n para el descubrimiento de nuevos antibi\u00f3ticos en Espa\u00f1a\",\"publisher\":{\"@id\":\"https:\/\/ad-es.es\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ad-es.es\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ad-es.es\/en\/#organization\",\"name\":\"AD-ES\",\"url\":\"https:\/\/ad-es.es\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ad-es.es\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ad-es.es\/en\/wp-content\/uploads\/sites\/5\/2021\/09\/logo1.png\",\"contentUrl\":\"https:\/\/ad-es.es\/en\/wp-content\/uploads\/sites\/5\/2021\/09\/logo1.png\",\"width\":426,\"height\":181,\"caption\":\"AD-ES\"},\"image\":{\"@id\":\"https:\/\/ad-es.es\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ad-es.es\/en\/#\/schema\/person\/02319ca6a45506b4328ab7ef566c3a8c\",\"name\":\"G3m4-tio-AD-ES\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ad-es.es\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6acf6ff0de3e40955d10395e600996a2e5ba7cf5afc5964faf543bd8bdf5d509?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6acf6ff0de3e40955d10395e600996a2e5ba7cf5afc5964faf543bd8bdf5d509?s=96&d=mm&r=g\",\"caption\":\"G3m4-tio-AD-ES\"},\"url\":\"https:\/\/ad-es.es\/en\/author\/g3m4-tio-ad-es\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Increasingly resistant bacteria with no innovative drugs for six decades - AD-ES","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/","og_locale":"en_US","og_type":"article","og_title":"Increasingly resistant bacteria with no innovative drugs for six decades - AD-ES","og_description":"La resistencia antimicrobiana es uno de los grandes problemas de la salud p\u00fablica mundial. Casi todos los antibi\u00f3ticos introducidos en el mercado son versiones mejoradas de los productos de amplio espectro aprobados antes de 1962. La OMS advierte de que la investigaci\u00f3n en este campo est\u00e1 &#8220;estancada&#8221;. Gargallo-Viola, CEO y CSO de ABAC Therapeutics, que [&hellip;]","og_url":"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/","og_site_name":"AD-ES","article_published_time":"2022-12-07T10:58:56+00:00","article_modified_time":"2025-05-28T08:49:09+00:00","author":"G3m4-tio-AD-ES","twitter_card":"summary_large_image","twitter_misc":{"Written by":"G3m4-tio-AD-ES","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/#article","isPartOf":{"@id":"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/"},"author":{"name":"G3m4-tio-AD-ES","@id":"https:\/\/ad-es.es\/en\/#\/schema\/person\/02319ca6a45506b4328ab7ef566c3a8c"},"headline":"Increasingly resistant bacteria with no innovative drugs for six decades","datePublished":"2022-12-07T10:58:56+00:00","dateModified":"2025-05-28T08:49:09+00:00","mainEntityOfPage":{"@id":"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/"},"wordCount":336,"publisher":{"@id":"https:\/\/ad-es.es\/en\/#organization"},"articleSection":["News of interest to AD-ES"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/","url":"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/","name":"Increasingly resistant bacteria with no innovative drugs for six decades - AD-ES","isPartOf":{"@id":"https:\/\/ad-es.es\/en\/#website"},"datePublished":"2022-12-07T10:58:56+00:00","dateModified":"2025-05-28T08:49:09+00:00","breadcrumb":{"@id":"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ad-es.es\/en\/bacterias-cada-vez-mas-resistentes-y-sin-farmacos-innovadores-desde-hace-seis-decadas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ad-es.es\/en\/"},{"@type":"ListItem","position":2,"name":"Increasingly resistant bacteria with no innovative drugs for six decades"}]},{"@type":"WebSite","@id":"https:\/\/ad-es.es\/en\/#website","url":"https:\/\/ad-es.es\/en\/","name":"AD-ES","description":"Asociaci\u00f3n para el descubrimiento de nuevos antibi\u00f3ticos en Espa\u00f1a","publisher":{"@id":"https:\/\/ad-es.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ad-es.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ad-es.es\/en\/#organization","name":"AD-ES","url":"https:\/\/ad-es.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ad-es.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ad-es.es\/en\/wp-content\/uploads\/sites\/5\/2021\/09\/logo1.png","contentUrl":"https:\/\/ad-es.es\/en\/wp-content\/uploads\/sites\/5\/2021\/09\/logo1.png","width":426,"height":181,"caption":"AD-ES"},"image":{"@id":"https:\/\/ad-es.es\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ad-es.es\/en\/#\/schema\/person\/02319ca6a45506b4328ab7ef566c3a8c","name":"G3m4-tio-AD-ES","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ad-es.es\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6acf6ff0de3e40955d10395e600996a2e5ba7cf5afc5964faf543bd8bdf5d509?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6acf6ff0de3e40955d10395e600996a2e5ba7cf5afc5964faf543bd8bdf5d509?s=96&d=mm&r=g","caption":"G3m4-tio-AD-ES"},"url":"https:\/\/ad-es.es\/en\/author\/g3m4-tio-ad-es\/"}]}},"_links":{"self":[{"href":"https:\/\/ad-es.es\/en\/wp-json\/wp\/v2\/posts\/2141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ad-es.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ad-es.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ad-es.es\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ad-es.es\/en\/wp-json\/wp\/v2\/comments?post=2141"}],"version-history":[{"count":3,"href":"https:\/\/ad-es.es\/en\/wp-json\/wp\/v2\/posts\/2141\/revisions"}],"predecessor-version":[{"id":2232,"href":"https:\/\/ad-es.es\/en\/wp-json\/wp\/v2\/posts\/2141\/revisions\/2232"}],"wp:attachment":[{"href":"https:\/\/ad-es.es\/en\/wp-json\/wp\/v2\/media?parent=2141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ad-es.es\/en\/wp-json\/wp\/v2\/categories?post=2141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ad-es.es\/en\/wp-json\/wp\/v2\/tags?post=2141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}